Oral disease in relation to future risk of dementia and cognitive decline: prospective cohort study based on the Action in Diabetes and Vascular Disease: Preterax and Diamicron Modified-Release Controlled Evaluation (ADVANCE) trial. (2013)

First Author: Batty GD
Attributed to:  Centre for Cognitive Ageing & Cognitive Epidemiology funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/j.eurpsy.2011.07.005

PubMed Identifier: 21964484

Publication URI: http://europepmc.org/abstract/MED/21964484

Type: Journal Article/Review

Volume: 28

Parent Publication: European psychiatry : the journal of the Association of European Psychiatrists

Issue: 1

ISSN: 0924-9338